These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18403755)

  • 1. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.
    Shu Q; Wong KK; Su JM; Adesina AM; Yu LT; Tsang YT; Antalffy BC; Baxter P; Perlaky L; Yang J; Dauser RC; Chintagumpala M; Blaney SM; Lau CC; Li XN
    Stem Cells; 2008 Jun; 26(6):1414-24. PubMed ID: 18403755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
    Baxter PA; Lin Q; Mao H; Kogiso M; Zhao X; Liu Z; Huang Y; Voicu H; Gurusiddappa S; Su JM; Adesina AM; Perlaky L; Dauser RC; Leung HC; Muraszko KM; Heth JA; Fan X; Lau CC; Man TK; Chintagumpala M; Li XN
    Acta Neuropathol Commun; 2014 Dec; 2():160. PubMed ID: 25526772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
    Chen KH; Hsu CC; Song WS; Huang CS; Tsai CC; Kuo CD; Hsu HS; Tsai TH; Tsai CY; Woung LC; Chiou SH; Lu KH; Chen YW
    Childs Nerv Syst; 2010 Nov; 26(11):1605-12. PubMed ID: 20526717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.
    Yu L; Baxter PA; Voicu H; Gurusiddappa S; Zhao Y; Adesina A; Man TK; Shu Q; Zhang YJ; Zhao XM; Su JM; Perlaky L; Dauser R; Chintagumpala M; Lau CC; Blaney SM; Rao PH; Leung HC; Li XN
    Neuro Oncol; 2010 Jun; 12(6):580-94. PubMed ID: 20511191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
    Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
    Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
    Wu A; Oh S; Wiesner SM; Ericson K; Chen L; Hall WA; Champoux PE; Low WC; Ohlfest JR
    Stem Cells Dev; 2008 Feb; 17(1):173-84. PubMed ID: 18271701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.
    Lee YY; Yang YP; Huang MC; Wang ML; Yen SH; Huang PI; Chen YW; Chiou SH; Lan YT; Ma HI; Shih YH; Chen MT
    Cell Transplant; 2014; 23(4-5):669-90. PubMed ID: 24816458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
    Srivastava VK; Nalbantoglu J
    Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
    Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation research between cancer stem cells and the pathological grades of neuroepithelial tumors].
    Deng YW; Fang JS; Li MC; Chen FH; Zhou XY; Wu J; Zhou RH; Fang F; Chen C; Lu M; Zeng FY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):45-51. PubMed ID: 16562674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133(+) cells isolated from various sources and their role in future clinical perspectives.
    Meregalli M; Farini A; Belicchi M; Torrente Y
    Expert Opin Biol Ther; 2010 Nov; 10(11):1521-8. PubMed ID: 20932225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell marker CD133 affects clinical outcome in glioma patients.
    Zeppernick F; Ahmadi R; Campos B; Dictus C; Helmke BM; Becker N; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende CC
    Clin Cancer Res; 2008 Jan; 14(1):123-9. PubMed ID: 18172261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human brain tumour initiating cells.
    Singh SK; Hawkins C; Clarke ID; Squire JA; Bayani J; Hide T; Henkelman RM; Cusimano MD; Dirks PB
    Nature; 2004 Nov; 432(7015):396-401. PubMed ID: 15549107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.
    Suetsugu A; Nagaki M; Aoki H; Motohashi T; Kunisada T; Moriwaki H
    Biochem Biophys Res Commun; 2006 Dec; 351(4):820-4. PubMed ID: 17097610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
    Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
    Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the complex regulation of CD133 in glioma.
    Campos B; Herold-Mende CC
    Int J Cancer; 2011 Feb; 128(3):501-10. PubMed ID: 20853315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.